Curcumin, a major component of the Curcuma species, contains antioxidant and anti-inflammatory properties. Although it was found to induce apoptosis in cancer cells, the functional role of curcumin as well as its molecular mechanism in anti-inflammatory response, particularly in intestinal cells, has been less investigated. The intestine epithelial barrier is the first barrier and the most important location for the substrate coming from the lumen of the gut. SUBJECTS/METHODS: We administered curcumin treatment in the human intestinal epithelial cell lines, T84 and Caco-2. We examined endoplasmic reticulum (ER) stress response by thapsigargin, qPCR of XBP1 and BiP, electrophysiology by wild-type cholera toxin in the cells.
INTRODUCTION 2)
Human gut epithelial barrier is the first and most important barrier for projection against foreign substrates such as a toxin or bacteria ingested through the mouth. Therefore it is not surprising that the gut epithelial cells are equipped with inflammation mechanisms of innate immunity for detection of microbes in the extracellular space and upon invasion.
Some viruses and bacterial toxins traffic through endoplasmic reticulum (ER) en route to the cytosol and are detected by ER sensors, called ER stress response. There are three ER stress receptors on the ER membrane, IRE1α, PERK, and ATF6 [1] . Among them, IRE1α is the most ancient and strongest receptor and it has been shown to play a role as a noble innate immune surveillance mechanism and in the inflammatory response [2] .
Turmeric, a phenolic compound from the plant Curcuma longa, is a flavoring agent used widely in food as a spice in curry powders and mustard. It has also been used as a medicine for treatment of clinical disease such as dysplasia and cancer [3, 4] in China and India. Mechanically, interaction of curcumin with growth factors, cytokines, and transcription factors at the cellular level has been studied extensively [5] . Therefore, it is not surprising that curcumin causes gastrointestinal inflammation when ingested. Curcumin is known to inhibit the activity of transcription factors such as nuclear factor-κB (NF-κB) [6, 7] , activated protein-1 (AP-1) [8] , and peroxisome proliferatoractivated receptor-γ (PPAR-γ) pathway [9] , which plays a role in cell survival, proliferation, and angiogenesis in intestinal inflammation [10] . However, curcumin exerts anti-inflammatory and growth-inhibition by inhibiting expression of interleukin-1β (IL-1β) [11] , interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) [12] in the cells. Despite its targets and substantial safety, the study of curcumin for pathogen toxicity has been limited in intestinal epithelial cells.
In this study, we examine the protective roles conferred by curcumin in intestine epithelial cells against bacterial invasion (or possibly ingested general pathogens), thereby inhibiting the inflammatory response pathway. type (wt) cholera toxin (CT) was purchased from Calbiochem (Billerica, MA).
Electrophysiology
Short-circuit current (Isc) and resistance measurements in electrophysiological studies on polarized T84 monolayer (0.33 cm 2 inserts) were performed as previously described [13] . All measurements are representative of at least three independent experiments.
Cell culture
Human intestinal epithelial T84 cells (ATCC, Manassas, VA) and Caco-2 (ATCC, Manassas, VA) were cultured in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum, 2% penicillin-streptomycin. The cells were incubated at 30°C and 5% CO2. In the experiments, all cell types were incubated with 3 nM wild-type Cholera Toxin apically, or 3 μM thapsigargin apically at various time points. Where indicated, cells were pretreated with curcumin at various concentrations for 24 hours.
Quantitative real-time qPCR
Total RNA of cells was extracted using the RNeasy® mini kit (Qiagen, Valencia, CA). cDNA was prepared from total RNA using the Superscript first-strand synthesis system (Invitrogen) with the oligo (dT) [12] [13] [14] [15] [16] [17] [18] primers, according to the manufacturer's instructions. RNA samples were treated with DNase I (Invitrogen) for elimination of genomic DNA. Human spliced form of XBP1 (forward: 5'-AACCAGGAGTTAAGACAGCGCTT-3', reverse: 5'-CTG CACCCTCTGCGGACT-3'), human BiP (forward: 5'-CATCACGCCG TCCTATGTCG-3', reverse: 5'-ATCGCCAATCAGACGTTCCC-3'). mRNA expression was determined by real-time qPCR using relative quantitation by the comparative threshold cycle number (Ct) method, iCycler, and SYBR Green Ready-mix (Bio-Rad, Hercules, CA) and normalized by housekeeping gene, GAPDH (forward: ATGGGGAAGGTGAAGGTCG-3', reverse: 5'-GGGGTCATTGATGGC AACAATA-3'). Preliminary experiments were performed with each primer pair to determine the amplification temperature that provided an optimal correlation between template concentration and signal intensity. At least three independent experiments were performed for each assay.
Confocal image analysis
T84 cells plated on 24-well Transwell® inserts (0.4 μm, polyester membranes, Costar) were washed and incubated with serum free T84 media in the basal chamber and serum free T84 media containing curcumin, thapsigargin, or wt CT in the apical side. Only high electrical resistance T84 monolayers cells were included in this study. For cell imaging, cells were washed with PBS before fixation with 4% paraformaldehyde (Electron Microscopy Sciences, PA) for 20 min at room temperature (RT) and permeabilized with 0.2% Saponin for ZO-1 or Triton-X100 for Phalloidin according to the instructions for the primary antibodies. All remaining steps were performed in a humidified chamber. The cells were blocked with 0.2% Saponin and 10% goat-serum in PBS for 30 min at RT. After several washes with PBS, the cells were incubated with ZO-1 (Molecular Probes, Grand Island, NY, 1 : 500) or TRITC-Phalloidin labeled with Alexafluor 568 (Tetramethylrhodamine, American Peptide, 1 : 5000) for 1 hour at RT. Cells labeled with ZO-1 were incubated with antimouse IgG-Alexafluor 488 secondary antibody (Invitrogen, 1 : 400) for 1 hour at RT. The nucleus was stained with DRAQ5 (Thermo Scientific, 1 : 1000) for 10 min at RT. Following extensive washes with PBS, the cells were mounted in the anti-fade medium Mowiol.
Statistical analysis
All data are representative of at least three independent experiments. Data are expressed as mean ± SEM unless otherwise indicated. Statistical significance of comparison between two groups was determined by two-tailed Student's t-test where indicated. One-way ANOVA was used for comparison of more than one group. Significant differences were considered at P-values of less than 0.05.
RESULT

Curcumin reduced the ER stress in human intestinal epithelial cells
To investigate the action of curcumin on the lumen of the intestinal epithelial layer, we administered curcumin treatment in the human intestinal epithelial cell lines, T84 and Caco-2. Two different intestinal cell lines were polarized to mimic the physiological environment with the apical side absorbing the nutrient and the basal side trafficking the nutrient from the lumen into the blood vessel through the extracellular matrix.
When there is an infection by bacteria or virus, toxins, the cells have their own way of recognizing the foreign substrate to alarm the system through the innate immune response. This foreign substrate can be taken up along with food, and absorbed into the gut epithelial barrier from the lumen via the mucin barrier. Then it traffics from the apical side to the basal side of the epithelial cells to enter the blood vessel. During trafficking, the ER of intestinal epithelial cells, one of the sensing organelles for detection of nutrients or toxins, binds to the ER membrane receptors and activates the ER stress pathway to alarm the mucosal immune response.
Therefore, we first examined the question of whether curcumin could affect ER stress in human intestinal epithelial cells. The cells were pretreated with different concentrations of curcumin for 24 hours, apically stimulating its absorption from the lumen into epithelial cells followed by apical treatment with thapsigargin, the reagent used most to stimulate ER stress. Surprisingly, BiP mRNA expression, the hallmark of ER stress, was significantly reduced by pretreatment with curcumin in a dosedependent manner (0, 0.1, and 1 μM) at different concentrations (0, 1, and 3 μM) of thapsigargin on T84 cells ( Fig. 1 A and B) and Caco-2 cells (Fig. 1 C and D) . Because the basal level of BiP mRNA differed in cells treated with different concentrations (0, 0.1, and 1 μM) of curcumin, we normalized the thapsigargininduced BiP expression by treatment with curcumin alone per each concentration of curcumin (Fig. 1B normalized for Fig. 1A intestinal epithelial cells.
Curcumin reduced IRE1α activation in human intestinal epithelial cells
The most abundant ER stress sensor is IRE1α. IRE1α is expressed ubiquitously, including intestinal epithelial cells. One of the known functions of IRE1α is its endonuclease activity, which cleaves several mRNAs of downstream genes, and the most well-known representative substrate is X-box binding protein 1 (XBP1). Cleaved XBP1 produces the spliced form of XBP1 (XBP1s). Therefore, we examined IRE1α activation by measuring its downstream molecule XBP1 mRNA level following curcumin treatment.
When we measured the spliced form of XBP1 from the mRNA of T84 cells (Fig. 2 A and B) and Caco-2 cells (Fig. 2 C and  D) in order to determine whether IRE1α, one of the ER stress sensors, is regulated by curcumin with preexisting ER stress, we found the same phenotype as BiP induction in both intestinal cell lines. The spliced XBP1 level was significantly increased by stimulation with thapsigargin, as shown in Fig. 2A , and this induction of XBP1 was significantly reduced by pretreatment with curcumin (3 μM thapsigargin with 0 μM of curcumin treatment versus 3uM thapsigargin with 0.1 μM or 1 μM of curcumin treatment). The higher concentration of curcumin (1 μM) inhibited XBP1s, a XBP1 splicing form, as compared to the lower concentration of curcumin (0.1 μM), indicating the dose-dependent response of curcumin in ER stress ( Fig. 2A) . When we normalized the XBP1 splicing form by the basal level from each curcumin concentration as described in Fig. 1 , the result of the XBP1s inhibition was more substantial in intestinal cells treated with curcumin ( Fig. 2B and Fig. 2D ). Note that we observed that increased curcumin concentration alone induces mRNA expression levels of XBP1s. This suggests that high dose curcumin alone induces ER stress relatively, which might induce the proinflammatory response.
Effect of curcumin on the anti-inflammatory response as a defense mechanism against bacterial invasion in intestinal epithelial cells
We next examined the question of whether curcumin has a protective mechanism against the pathogen, which can be ingested orally (wild-type cholera toxin in our study), and inhibits the proinflammatory response in the lumen of the intestine.
First, to determine whether curcumin treatment shows proinflammatory response by ER stress, the polarized intestinal cell line T84 was pretreated with or without curcumin for 24 hours followed by thapsigargin, as an ER stress inducer. We measured IL-8 mRNA expression level, a representative cytokine for NF-κB activation as a well-known of inflammatory pathway. As expected, thapsigargin induced the IL-8 mRNA level in a dose dependent manner (0, 1 and 3 μM). And, interestingly, treatment with curcumin reduced this IL-8 induction by thapsigargin in a dose dependent manner relatively (0, 0.1, and 1 μM) (see Fig. 4A ).
Cholera toxin increases the ion current on the polarized T84 cell monolayer (measured by a real-time electrophysiology) due to raised cAMP level followed by ion channel opening, indicating the toxicity of pathogen (18) . We therefore determined whether curcumin reduces pathogen toxicity, at least cholera toxin, in intestinal epithelial T84 cells. Toxicity is plotted on the Y-axis as a short circuit current, and time on the horizontal. As shown here, only the wild-type cholera toxin causes full toxicity when applied to T84 cells. Cells pretreated with curcumin showed half of the toxicity from the wild-type cholera toxin.
The polarized intestinal epithelial cell line T84 with/without pretreatment of curcumin for 24 hours was intoxicated with the wild-type cholera toxin, and the ion channel current (Isc, mA/cm 2 ) was measured by electrophysiology in real time. As shown in Fig. 3B , a wild-type cholera toxin only started to induce toxicity (Isc, mA/cm 2 ) 15 min after intoxication. However the intoxicated T84 cells pretreated with curcumin showed delayed toxicity starting from 45 min after intoxication, with almost half the level of full toxicity as compared to intestinal epithelial cells induced by treatment with a wild-type cholera toxin alone. As expected, neither buffer of the negative control, nor curcumin treatment itself showed toxicity (See Fig. 3B ). Collectively, curcumin delays the toxicity caused by the pathogen (at least cholera toxin) in the lumen and its maximum toxicity level is also reduced. The data in this study suggest the anti-toxicity action of curcumin.
Next, we determined whether curcumin affects ER stress response and inflammatory response induced by wild-type cholera toxin. BiP mRNA expression level, as a marker for ER stress (Fig. 3C) , and IL-8 mRNA expression level as a marker for the inflammatory response (Fig. 3D) , were measured on polarized intestinal Caco-2 cells pretreated with curcumin for 24 hours, followed by 3nM wild-type cholera toxin for another 24 hours.
Curcumin itself slightly induced the BiP mRNA level in Caco-2 cells (0, 0.1, 1, and 10 μM of curcumin), while it effectively inhibited the BiP mRNA level, which was induced by wild-type cholera toxin (0 nM versus 3 nM treatment of cholera toxin) in a dose dependent manner (Fig. 3C) .
As shown in Fig. 3D , there was no induction of IL-8 mRNA level even with the highest concentration of curcumin (0 verse 10 μM of curcumin) in Caco-2 cells as well as T84 cells (Data not shown). Pretreatment with curcumin inhibited IL-8 induction by the wild-type cholera toxin in Caco-2 cells (Fig. 3D) . This result suggests that curcumin treatment showed anti-inflammatory response in both T-84 and Caco-2 intestinal epithelial cells exposed to the pathogen, such as cholera toxin. Taken together, these data further indicate the protective function of curcumin in anti-inflammatory response by reducing ER stress against the pathogen in intestinal epithelial cells.
Curcumin causes no change of the tight junction in human intestinal epithelial cells
Furthermore, due to its potential toxicity, we wanted to confirm whether doses of curcumin used in this study affect the barrier function of polarized monolayer epithelial cells.
When the cells were pretreated with curcumin for 24 hours before stimulation with 40 nM wild-type cholera toxin for another 24 hours, the tight junctions of the cells were intact, as shown with an anti-ZO-1 antibody, which is used as a marker for a tight junction (See Fig. 4A, right panels) . In addition, we observed an actin skeleton of the cells using an anti-Phalloidin antibody in order to understand whether there is any change of the actin skeleton of the intestinal epithelial cells by curcumin (Fig. 4A, left panels) . There was no change in the tight junction or actin skeleton by 1 μM of curcumin even in the presence of cholera toxin. Collectively, curcumin treatment itself is not harmful to the epithelial barrier even in the presence of inflammatory response to the pathogen.
DISCUSSION
The intestine consists of the small intestine and the large intestine, which is the major location of nutrient absorption as well as contact with pathogens/bacteria or their secreted toxins. The intestinal epithelial cell barrier is the first location of defense for innate immunity. In addition, intestinal immunity includes Peyer's patches (small intestine), lymphoid follicles, Mesenchyme lymph node (MLN), and colonic patches (large intestine) [14, 15] .
Microbial communities (microbiota) and pathogens influence the immune system and inflammation in the intestine. MUC2 is the most abundant protein of intestine mucus. Genetically engineered mice bearing MUC2 missense mutations develop chronic inflammation in their intestine. Mutant MUC2 mice induce stress in the endoplasmic reticulum (ER) and initiation of the unfolded protein response (UPR). The previous study showed evidence of ER stress and accumulation of inflammatory response [16] . NF-kB pathway is dominantly observed in inflammatory response of the intestine [15] . Receptor families such as IL-8, IL-11, and TNFα include activation of NF-κB signal transduction. The NF-κB refers to a group of transcription factors that regulate the expression of many genes encoding proteins which are broadly involved in immune and inflam-matory response, cell death, cell cycle regulation, cell proliferation, and cell migration [17, 18] . IKKα, IKKβ, and IKKγ (NF-κB essential modulator, NEMO) form the IKK complex, which phosphorylates IκBs [19, 20] . The phosphorylation induces IκBα protein degradation, allowing movement of the free NF-κB to the nucleus, as a transcription factor. The effect of curcumin on inflammation is still unknown.
Several studies have reported evidence of a functional association of curcumin with intestine inflammatory disease, such as inflammatory bowel disease (IBD) [7] . Our data show that treatment with curcumin resulted in a reduction of BiP mRNA levels and IL-8 mRNA levels after cholera intoxication. Our study indicates that toxicity of cholera or pathogen might be controlled by curcumin treatment. Curcumin can reduce ER stress induction by thapsigargin or cholera toxin and thereby lead to reduction in inflammatory response (Fig. 4B) . In addition, our study indicates that curcumin can also reduce the toxicity of pathogen. Using the electrophysiology assay, it was shown that curcumin treatment can reduce and delay the toxicity of wild-type cholera. Taken together, our study provides new evidence of the effect of curcumin in reducing ER stress and anti-inflammation in the intestine.
Finally, our data suggest that long-term or consistent intake of curcumin-containing food might prevent early bacterial or virus infection into the lumen of the intestine or reduce the degree of the infection by inhibiting the inflammatory response and an ER stress response from the intestinal epithelial barriers. In addition, it might imply that long-term intake of curcumincontaining food as a natural eco-biological ingredient might reduce the symptoms of inflammation in the intestine of IBD patients as a secondary treatment with few pharmaceutical side effects.
